GLMP
Glycosylated lysosomal membrane protein
Also known as: C1orf85, GLMP_HUMAN, MGC31963, NCU-G1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WWB7
- Gene
- GLMP
- Ensembl
- ENSG00000198715
- Chromosome
- 1
- Canonical length
- 406 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Involved in positive regulation of transcription by RNA polymerase II. Located in cytosol; lysosome; and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
406 residues, UniProt reviewed canonical sequence.
>Q8WWB7|GLMP
1 MRGSVECTWG WGHCAPSPLL LWTLLLFAAP FGLLGEKTRQ VSLEVIPNWL GPLQNLLHIR
61 AVGTNSTLHY VWSSLGPLAV VMVATNTPHS TLSVNWSLLL SPEPDGGLMV LPKDSIQFSS
121 ALVFTRLLEF DSTNVSDTAA KPLGRPYPPY SLADFSWNNI TDSLDPATLS ATFQGHPMND
181 PTRTFANGSL AFRVQAFSRS SRPAQPPRLL HTADTCQLEV ALIGASPRGN RSLFGLEVAT
241 LGQGPDCPSM QEQHSIDDEY APAVFQLDQL LWGSLPSGFA QWRPVAYSQK PGGRESALPC
301 QASPLHPALA YSLPQSPIVR AFFGSQNNFC AFNLTFGAST GPGYWDQHYL SWSMLLGVGF
361 PPVDGLSPLV LGIMAVALGA PGLMLLGGGL VLLLHHKKYS EYQSINLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GLMP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 64 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 64 nTPM
- liver: 58 nTPM
- prostate: 55 nTPM
- kidney: 51 nTPM
- choroid plexus: 47 nTPM
- placenta: 45 nTPM
Single-cell type
- hofbauer cells: 335 nCPM
- esophageal apical cells: 106 nCPM
- kupffer cells: 94 nCPM
- extravillous trophoblasts: 92 nCPM
- hepatocytes: 84 nCPM
- syncytiotrophoblasts: 81 nCPM
Immune cell
- intermediate monocyte: 75 nTPM
- classical monocyte: 71 nTPM
- non-classical monocyte: 56 nTPM
- T-reg: 44 nTPM
- total PBMC: 37 nTPM
- basophil: 35 nTPM
Brain region
- choroid plexus: 31 nTPM
- thalamus: 21 nTPM
- pons: 18 nTPM
- white matter: 16 nTPM
- hypothalamus: 15 nTPM
- midbrain: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.45
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of transcription by RNA polymerase II
- protein localization to lysosome
- protein stabilization
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glycosylated lysosomal membrane protein
- Lysosomal transcription factor, NCU-G1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GLMP as an antibody target. Whether an autoantibody or antibody against GLMP could matter depends on whether native GLMP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GLMP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GLMP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...